标题
Recent progress in the development of Toll-like receptor (TLR) antagonists
作者
关键词
-
出版物
EXPERT OPINION ON THERAPEUTIC PATENTS
Volume 26, Issue 6, Pages 719-730
出版商
Informa UK Limited
发表日期
2016-05-02
DOI
10.1080/13543776.2016.1185415
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The critical role of toll-like receptors — From microbial recognition to autoimmunity: A comprehensive review
- (2016) Maximiliano Javier Jiménez-Dalmaroni et al. AUTOIMMUNITY REVIEWS
- Pharmacological characterization of the opioid inactive isomers (+)-naltrexone and (+)-naloxone as antagonists of toll-like receptor 4
- (2016) X Wang et al. BRITISH JOURNAL OF PHARMACOLOGY
- Identification of a Human Toll-Like Receptor (TLR) 8-Specific Agonist and a Functional Pan-TLR Inhibitor in 2-Aminoimidazoles
- (2016) Mallesh Beesu et al. JOURNAL OF MEDICINAL CHEMISTRY
- Toll-like receptors: potential targets for lupus treatment
- (2015) Yan-wei Wu et al. ACTA PHARMACOLOGICA SINICA
- Microbially Driven TLR5-Dependent Signaling Governs Distal Malignant Progression through Tumor-Promoting Inflammation
- (2015) Melanie R. Rutkowski et al. CANCER CELL
- Pyrimidine Triazole Thioether Derivatives as Toll-Like Receptor 5 (TLR5)/Flagellin Complex Inhibitors
- (2015) Lei Yan et al. ChemMedChem
- Patents for Toll-like receptor ligands as radiation countermeasures for acute radiation syndrome
- (2015) Vijay K Singh et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Leucine-rich repeat 2 of human Toll-like receptor 4 contains the binding site for inhibitory monoclonal antibodies
- (2015) Hiroki Tsukamoto et al. FEBS LETTERS
- A randomized trial of Mycobacterium w in severe sepsis
- (2015) Inderpaul Singh Sehgal et al. JOURNAL OF CRITICAL CARE
- Toll-like Receptor 10 inHelicobacter pyloriInfection
- (2015) Hiroyuki Nagashima et al. JOURNAL OF INFECTIOUS DISEASES
- Structure–Activity Relationships of (+)-Naltrexone-Inspired Toll-like Receptor 4 (TLR4) Antagonists
- (2015) Brandon R. Selfridge et al. JOURNAL OF MEDICINAL CHEMISTRY
- Control of adaptive immunity by the innate immune system
- (2015) Akiko Iwasaki et al. NATURE IMMUNOLOGY
- Structural basis for inhibition of TLR2 by staphylococcal superantigen-like protein 3 (SSL3)
- (2015) Kirsten J. Koymans et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Inhibition of TLR2 signaling by small molecule inhibitors targeting a pocket within the TLR2 TIR domain
- (2015) Pragnesh Mistry et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A Decoy Peptide that Disrupts TIRAP Recruitment to TLRs Is Protective in a Murine Model of Influenza
- (2015) Wenji Piao et al. Cell Reports
- Prospective Virtual Screening in a Sparse Data Scenario: Design of Small-Molecule TLR2 Antagonists
- (2014) Manuela S. Murgueitio et al. ChemMedChem
- The use of low-dose naltrexone (LDN) as a novel anti-inflammatory treatment for chronic pain
- (2014) Jarred Younger et al. CLINICAL RHEUMATOLOGY
- Toll-like receptor agonists: a patent review (2011 – 2013)
- (2014) Waleed M Hussein et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Effects of Hydroxychloroquine on Symptomatic Improvement in Primary Sjögren Syndrome
- (2014) Jacques-Eric Gottenberg et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Vizantin Inhibits Endotoxin-Mediated Immune Responses via the TLR 4/MD-2 Complex
- (2014) Masataka Oda et al. JOURNAL OF IMMUNOLOGY
- Sequence-dependent off-target inhibition of TLR7/8 sensing by synthetic microRNA inhibitors
- (2014) Soroush T. Sarvestani et al. NUCLEIC ACIDS RESEARCH
- UNC93B1 is essential for the plasma membrane localization and signaling of Toll-like receptor 5
- (2014) J.-W. Huh et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Toll-like receptor 10 is involved in induction of innate immune responses to influenza virus infection
- (2014) S. M. Y. Lee et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Blockade of TLR3 protects mice from lethal radiation-induced gastrointestinal syndrome
- (2014) Naoki Takemura et al. Nature Communications
- Functional TLR5 Genetic Variants Affect Human Colorectal Cancer Survival
- (2013) S. N. Klimosch et al. CANCER RESEARCH
- Modulation of CD14 and TLR4⋅MD-2 Activities by a Synthetic Lipid A Mimetic
- (2013) Roberto Cighetti et al. CHEMBIOCHEM
- Randomized, Double-Blind, Placebo-Controlled, Dose-Escalating Phase I, Healthy Subjects Study of Intravenous OPN-305, a Humanized Anti-TLR2 Antibody
- (2013) M Reilly et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- TLR2 and TLR4 in Autoimmune Diseases: a Comprehensive Review
- (2013) Yu Liu et al. CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY
- Effect of Eritoran, an Antagonist of MD2-TLR4, on Mortality in Patients With Severe Sepsis
- (2013) Steven M. Opal et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Identification of TLR10 as a Key Mediator of the Inflammatory Response to Listeria monocytogenes in Intestinal Epithelial Cells and Macrophages
- (2013) T. Regan et al. JOURNAL OF IMMUNOLOGY
- A Novel Small-Molecule Enantiomeric Analogue of Traditional (-)-Morphinans Has Specific TLR9 Antagonist Properties and Reduces Sterile Inflammation-Induced Organ Damage
- (2013) R. Hoque et al. JOURNAL OF IMMUNOLOGY
- CD103−CD11b+ dendritic cells regulate the sensitivity of CD4 T-cell responses to bacterial flagellin
- (2013) S M Atif et al. Mucosal Immunology
- The TLR4 antagonist Eritoran protects mice from lethal influenza infection
- (2013) Kari Ann Shirey et al. NATURE
- A toll-like receptor 9 antagonist reduces pain hypersensitivity and the inflammatory response in spinal cord injury
- (2013) Brian T. David et al. NEUROBIOLOGY OF DISEASE
- Design, synthesis and biological evaluation of novel antagonist compounds of Toll-like receptors 7, 8 and 9
- (2013) Ekambar R. Kandimalla et al. NUCLEIC ACIDS RESEARCH
- Structural Reorganization of the Toll-Like Receptor 8 Dimer Induced by Agonistic Ligands
- (2013) H. Tanji et al. SCIENCE
- Targeting Toll-Like Receptors: Promising Therapeutic Strategies for the Management of Sepsis-Associated Pathology and Infectious Diseases
- (2013) Athina Savva et al. Frontiers in Immunology
- Fine-Tuning Multiprotein Complexes Using Small Molecules
- (2012) Andrea D. Thompson et al. ACS Chemical Biology
- Discovery of Small-Molecule Inhibitors of the TLR1/TLR2 Complex
- (2012) Kui Cheng et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Treatment With OPN-305, a Humanized Anti–Toll-Like Receptor-2 Antibody, Reduces Myocardial Ischemia/Reperfusion Injury in Pigs
- (2012) Fatih Arslan et al. Circulation-Cardiovascular Interventions
- The Role of UNC93B1 Protein in Surface Localization of TLR3 Receptor and in Cell Priming to Nucleic Acid Agonists
- (2012) Jelka Pohar et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Lateral Clustering of TLR3:dsRNA Signaling Units Revealed by TLR3ecd:3Fabs Quaternary Structure
- (2012) Jinquan Luo et al. JOURNAL OF MOLECULAR BIOLOGY
- Toll-like receptors in transplantation: sensing and reacting to injury
- (2012) Jeremy S. Leventhal et al. KIDNEY INTERNATIONAL
- Morphine activates neuroinflammation in a manner parallel to endotoxin
- (2012) X. Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Structural Basis of TLR5-Flagellin Recognition and Signaling
- (2012) S.-i. Yoon et al. SCIENCE
- Prevention and diminished expression of experimental autoimmune encephalomyelitis by low dose naltrexone (LDN) or opioid growth factor (OGF) for an extended period: Therapeutic implications for multiple sclerosis
- (2011) Kristen A. Rahn et al. BRAIN RESEARCH
- Innate immune DNA sensing pathways: STING, AIMII and the regulation of interferon production and inflammatory responses
- (2011) Glen N Barber CURRENT OPINION IN IMMUNOLOGY
- Therapy with the Opioid Antagonist Naltrexone Promotes Mucosal Healing in Active Crohn’s Disease: A Randomized Placebo-Controlled Trial
- (2011) Jill P. Smith et al. DIGESTIVE DISEASES AND SCIENCES
- Toll-like receptor modulators: a patent review (2006 – 2010)
- (2011) Shaherin Basith et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Immune Signaling by RIG-I-like Receptors
- (2011) Yueh-Ming Loo et al. IMMUNITY
- Myeloid C-type Lectin Receptors in Pathogen Recognition and Host Defense
- (2011) Fabiola Osorio et al. IMMUNITY
- Regulation of the Antimicrobial Response by NLR Proteins
- (2011) Eran Elinav et al. IMMUNITY
- Toll-like Receptors and Their Crosstalk with Other Innate Receptors in Infection and Immunity
- (2011) Taro Kawai et al. IMMUNITY
- Optimal oligonucleotide sequences for TLR9 inhibitory activity in human cells: lack of correlation with TLR9 binding
- (2011) Robert F. Ashman et al. INTERNATIONAL IMMUNOLOGY
- Contribution of Different Mechanisms to Pancreatic Beta-cell Hyper-secretion in Non-obese Diabetic (NOD) Mice during Pre-diabetes
- (2011) Kuo Liang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Herpes simplex virus encephalitis in a patient with complete TLR3 deficiency: TLR3 is otherwise redundant in protective immunity
- (2011) Yiqi Guo et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Targeting TLR4 Signaling by TLR4 Toll/IL-1 Receptor Domain-Derived Decoy Peptides: Identification of the TLR4 Toll/IL-1 Receptor Domain Dimerization Interface
- (2011) V. Y. Toshchakov et al. JOURNAL OF IMMUNOLOGY
- Mechanism of Endosomal TLR Inhibition by Antimalarial Drugs and Imidazoquinolines
- (2011) A. Kuznik et al. JOURNAL OF IMMUNOLOGY
- Small-Molecule Inhibitors of the TLR3/dsRNA Complex
- (2011) Kui Cheng et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Therapeutical targeting of nucleic acid-sensing Toll-like receptors prevents experimental cerebral malaria
- (2011) Bernardo S. Franklin et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Structural Biology of Toll-like Receptors
- (2011) Istvan Botos et al. STRUCTURE
- A randomized, double-blind, placebo-controlled trial of TAK-242 for the treatment of severe sepsis*
- (2010) Todd W. Rice et al. CRITICAL CARE MEDICINE
- TAK-242 (Resatorvid), a Small-Molecule Inhibitor of Toll-Like Receptor (TLR) 4 Signaling, Binds Selectively to TLR4 and Interferes with Interactions between TLR4 and Its Adaptor Molecules
- (2010) N. Matsunaga et al. MOLECULAR PHARMACOLOGY
- IFI16 is an innate immune sensor for intracellular DNA
- (2010) Leonie Unterholzner et al. NATURE IMMUNOLOGY
- The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors
- (2010) Taro Kawai et al. NATURE IMMUNOLOGY
- Targeting Toll-like receptors: emerging therapeutics?
- (2010) Elizabeth J. Hennessy et al. NATURE REVIEWS DRUG DISCOVERY
- Metabolic Syndrome and Altered Gut Microbiota in Mice Lacking Toll-Like Receptor 5
- (2010) M. Vijay-Kumar et al. SCIENCE
- Selection, Preparation, and Evaluation of Small-Molecule Inhibitors of Toll-Like Receptor 4
- (2010) Douglas E. Bevan et al. ACS Medicinal Chemistry Letters
- Stilbene glycosides are natural product inhibitors of FGF-2-induced angiogenesis
- (2009) Sajjad Hussain et al. BMC CELL BIOLOGY
- Recognition of Lipopeptide Patterns by Toll-like Receptor 2-Toll-like Receptor 6 Heterodimer
- (2009) Jin Young Kang et al. IMMUNITY
- AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA
- (2009) Teresa Fernandes-Alnemri et al. NATURE
- Toll-Like Receptor 3 Signaling on Macrophages Is Required for Survival Following Coxsackievirus B4 Infection
- (2009) Martin J. Richer et al. PLoS One
- Antimalarial Activity of a New Stilbene Glycoside from Parthenocissus tricuspidata in Mice
- (2008) W.-H. Park et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- TLRs and innate immunity
- (2008) B. A. Beutler BLOOD
- Functional diversification of the toll-like receptor gene family
- (2008) Austin L. Hughes et al. IMMUNOGENETICS
- An Agonist of Toll-Like Receptor 5 Has Radioprotective Activity in Mouse and Primate Models
- (2008) L. G. Burdelya et al. SCIENCE
- Structural Basis of Toll-Like Receptor 3 Signaling with Double-Stranded RNA
- (2008) L. Liu et al. SCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started